Search

Sarepta Therapeutics anuncia convocatoria de solicitudes para el 6.º Route 79 anual, el programa de becas Duchenne
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
RNA Platform
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments
Notice on Cookies
Community Letter: SRP-9001 Advisory Committee Meeting will be held
Sarepta Therapeutics Announces Advisory Committee Meeting will be Held for SRP-9001
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Community Letter: SRP-9001 Advisory Committee Date is Announced
Sarepta Therapeutics Announces that the Date of the Advisory Committee Meeting for SRP-9001 will be May 12, 2023